Claudia Crosio

3.4k total citations · 1 hit paper
36 papers, 2.7k citations indexed

About

Claudia Crosio is a scholar working on Neurology, Molecular Biology and Physiology. According to data from OpenAlex, Claudia Crosio has authored 36 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 17 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in Claudia Crosio's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Amyotrophic Lateral Sclerosis Research (9 papers) and Alzheimer's disease research and treatments (8 papers). Claudia Crosio is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Amyotrophic Lateral Sclerosis Research (9 papers) and Alzheimer's disease research and treatments (8 papers). Claudia Crosio collaborates with scholars based in Italy, United States and France. Claudia Crosio's co-authors include Paolo Sassone‐Corsi, C. David Allis, Maria Teresa Carrı̀, Ciro Iaccarino, Lucia Monaco, Yukio Okano, Subrata Sen, Masashi Kimura, Gian María Fimia and Hongyi Zhou and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Claudia Crosio

35 papers receiving 2.6k citations

Hit Papers

Mitotic Phosphorylation of Histone H3: Spatio-Temporal Re... 2002 2026 2010 2018 2002 100 200 300 400 500

Peers

Claudia Crosio
Esther B. E. Becker United Kingdom
Stefan Wiese Germany
Louis J. DeGennaro United States
Damian C. Crowther United Kingdom
Shusei Hamamichi United States
Neelam Shahani United States
Sung‐Wuk Jang South Korea
Udai Bhan Pandey United States
Esther B. E. Becker United Kingdom
Claudia Crosio
Citations per year, relative to Claudia Crosio Claudia Crosio (= 1×) peers Esther B. E. Becker

Countries citing papers authored by Claudia Crosio

Since Specialization
Citations

This map shows the geographic impact of Claudia Crosio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Crosio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Crosio more than expected).

Fields of papers citing papers by Claudia Crosio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Crosio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Crosio. The network helps show where Claudia Crosio may publish in the future.

Co-authorship network of co-authors of Claudia Crosio

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Crosio. A scholar is included among the top collaborators of Claudia Crosio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Crosio. Claudia Crosio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pala, Nicolino, Wojciech Szlasa, Carrie L. Lomelino, et al.. (2025). Design, anticancer activity, and mechanistic evaluation of a novel class of selective human carbonic anhydrase IX inhibitors featuring a trifluorodihydroxypropanone pharmacophore. European Journal of Medicinal Chemistry. 298. 118043–118043. 1 indexed citations
2.
Galleri, Grazia, Manuela Galioto, Bachisio Mario Padedda, et al.. (2024). Evaluation of cyanotoxin L-BMAA effect on α-synuclein and TDP43 proteinopathy. Frontiers in Immunology. 15. 1360068–1360068.
3.
Galleri, Grazia, Lucia Iannotta, Manuela Galioto, et al.. (2023). Inhibition of the Exocyst Complex Attenuates the LRRK2 Pathological Effects. International Journal of Molecular Sciences. 24(16). 12656–12656. 2 indexed citations
4.
Biosa, Alice, Manuela Galioto, Elisa Greggio, et al.. (2019). Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype. Journal of Cellular and Molecular Medicine. 23(12). 8505–8510. 9 indexed citations
5.
Galioto, Manuela, Angelo Zinellu, Ciriaco Carru, et al.. (2018). Epigenetic Changes Associated with the Expression of Amyotrophic Lateral Sclerosis (ALS) Causing Genes. Neuroscience. 390. 1–11. 26 indexed citations
6.
Taymans, Jean‐Marc, Michele Morari, Alberto Brugnoli, et al.. (2017). Role of LRRK2 in the regulation of dopamine receptor trafficking. PLoS ONE. 12(6). e0179082–e0179082. 56 indexed citations
7.
Sechi, Mario, Vanna Sanna, Nicolino Pala, et al.. (2014). Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities. International Journal of Nanomedicine. 9. 4935–4935. 98 indexed citations
8.
Migheli, Rossana, Ylenia Spissu, Giovanna Sanna, et al.. (2013). LRRK2 Affects Vesicle Trafficking, Neurotransmitter Extracellular Level and Membrane Receptor Localization. PLoS ONE. 8(10). e77198–e77198. 59 indexed citations
9.
Iaccarino, Ciro, Franco Carta, Giovanna Sanna, et al.. (2011). Bcl2-A1 interacts with pro-caspase-3: Implications for amyotrophic lateral sclerosis. Neurobiology of Disease. 43(3). 642–650. 12 indexed citations
10.
Crosio, Claudia, Cristiana Valle, Arianna Casciati, Ciro Iaccarino, & Maria Teresa Carrı̀. (2011). Astroglial Inhibition of NF-κB Does Not Ameliorate Disease Onset and Progression in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS). PLoS ONE. 6(3). e17187–e17187. 54 indexed citations
11.
Cozzolino, Mauro, Maria Grazia Pesaresi, Claudia Crosio, et al.. (2009). Oligomerization of Mutant SOD1 in Mitochondria of Motoneuronal Cells Drives Mitochondrial Damage and Cell Toxicity. Antioxidants and Redox Signaling. 11(7). 1547–1558. 74 indexed citations
12.
Iaccarino, Ciro, Claudia Crosio, Carmine Vitale, et al.. (2007). Apoptotic mechanisms in mutant LRRK2-mediated cell death. Human Molecular Genetics. 16(11). 1319–1326. 155 indexed citations
13.
Danzeisen, Ruth, Tilmann Achsel, Mauro Cozzolino, et al.. (2006). Superoxide dismutase 1 modulates expression of transferrin receptor. JBIC Journal of Biological Inorganic Chemistry. 11(4). 489–498. 38 indexed citations
14.
Crosio, Claudia, Gian María Fimia, Masashi Kimura, et al.. (2002). Mitotic Phosphorylation of Histone H3: Spatio-Temporal Regulation by Mammalian Aurora Kinases. Molecular and Cellular Biology. 22(3). 874–885. 529 indexed citations breakdown →
15.
Hans, Aymeric, Sylvie Syan, Claudia Crosio, et al.. (2001). Borna Disease Virus Persistent Infection Activates Mitogen-activated Protein Kinase and Blocks Neuronal Differentiation of PC12 Cells. Journal of Biological Chemistry. 276(10). 7258–7265. 43 indexed citations
16.
Crosio, Claudia, Nicolas Cermakian, C. David Allis, & Paolo Sassone‐Corsi. (2000). Light induces chromatin modification in cells of the mammalian circadian clock. Nature Neuroscience. 3(12). 1241–1247. 207 indexed citations
17.
Crosio, Claudia. (2000). La protein has a positive effect on the translation of TOP mRNAs in vivo. Nucleic Acids Research. 28(15). 2927–2934. 75 indexed citations
18.
Sassone‐Corsi, Paolo, Craig A. Mizzen, Peter Cheung, et al.. (1999). Requirement of Rsk-2 for Epidermal Growth Factor-Activated Phosphorylation of Histone H3. Science. 285(5429). 886–891. 408 indexed citations
19.
Crosio, Claudia, Francesco Cecconi, Paolo Mariottini, et al.. (1996). Fugu intron oversize reveals the presence of U15 snoRNA coding sequences in some introns of the ribosomal protein S3 gene.. Genome Research. 6(12). 1227–1231. 11 indexed citations
20.
Pellizzoni, Livio, Claudia Crosio, & Paola Pierandrei‐Amaldi. (1995). Sequence of the cDNA and gene coding for ribosomal protein S 1 of Xenopus laevis. Gene. 154(2). 145–151. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026